ProQR Therapeutics N.V.
IPOProQR Therapeutics - Creating RNA therapies for patients in need
Public · Netherlands · Founded 2012
- Founded
- 2012
- Business Model
- B2B
- Website
- proqr.com
- Type
- Public
About
ProQR Therapeutics is a biotechnology company developing RNA therapies for severe rare and common diseases, with a focus on its proprietary Axiomer RNA-editing platform. The company has offices in Leiden, the Netherlands and Cambridge, Massachusetts. Founded in 2012 with a mission to help people living with rare diseases that currently have no treatment options, ProQR integrates the patient voice throughout drug development. It is listed on Nasdaq as PRQR.
Summary
ProQR Therapeutics N.V. is a Biotech company based in Netherlands, founded in 2012.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/proqr-therapeutics-n-v"><img src="https://indexed.vc/api/badge/company/proqr-therapeutics-n-v" alt="ProQR Therapeutics N.V. on Indexed.vc" width="260" height="76" /></a>